Abbott Laboratories (ABT) Wednesday received U.S. Food and Drug Administration approval for two new dosage strengths of SIMCOR, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release.
SIMCOR is a prescription medication used along with diet in people who cannot control their cholesterol levels by diet and exercise alone, the company said.
For comments and feedback: editorial@rttnews.com